We investigated the changes and the molecular mechanisms of cerebral vascular damage after stroke in type-2 diabetic (T2DM) mice. Adult male db/db T2DM and wild-type (WT) mice were subjected to transient middle cerebral artery occlusion (MCAo) and sacrificed 24 hours after MCAo. T2DM-mice exhibited significantly increased blood glucose, brain hemorrhagic rate, mortality and cerebrovascular density, but decreased cerebrovascular diameter, arteriolar density and arterial mural cell numbers in the ischemic brain compared with WT mice. The hemorrhagic rate was significantly correlated with the mortality (r = 0.85). T2DM-mice also exhibited increased blood-brain barrier leakage and concomitantly, increased Angiopoietin2, but decreased Angiopoietin1, Tie2 and tight junction protein expression in the ischemic brain. Angiopoietin1 gene expression also significantly decreased in the common carotid artery (CCA) in T2DM-mice compared with WT mice after stroke. To further test the effects of T2DM on cerebrovascular damage, we performed in vitro studies. The capillary-like tube formation of primary cultured mouse brain endothelial cells (MBECs) significantly increased, but artery cell migration in the primary CCA cultures significantly decreased both in Sham and MCAo T2DM-mice compared with the WT mice. Angiopoietin1 treatment significantly increased artery cell migration in T2DM-CCA after MCAo. Tie2-FC, a neutralized Tie2 antibody, significantly decreased artery cell migration in WT-CCA after MCAo. Therefore, decreased Angiopoietin1/Tie2 and increased Angiopoietin2 expression may contribute to diabetes-induced vascular damage after stroke.
Introduction
Diabetes mellitus (DM) is a major health problem associated with both microvascular and macrovascular disease and is a high risk factor for ischemic stroke (Basu et al., 2005) . Clinical studies show that hyperglycemia increases mortality and leads to poor functional recovery in both diabetic and non-diabetic patients after stroke (Capes et al., 2001) . Hyperglycemia and DM increase the blood-brain barrier (BBB) permeability and infarct volume (Ennis and Keep, 2007; Mooradian et al., 2005) after stroke in rats. However, the molecular mechanisms underlying DM-induced vascular damage after stroke require clarification.
Angiopoietin1 (Ang1) belongs to a family of endothelial growth factors;promotes migration, sprouting, and survival of endothelial cells; and mediates vascular remodeling through activation of signaling pathways triggered by the Tie2 tyrosine kinase receptor (Suri et al., 1996) . Transgenic over-expression of Ang1 increases vascularization (Suri et al., 1998) , prevents plasma leakage in the ischemic brain, and consequently decreases ischemic lesion volume (Zhang et al., 2002 ). An Ang1 peptide mimetic treatment accelerates wound healing in diabetes animals (Liu et al., 2008; Van Slyke et al., 2009 ). Angiopoietin2 (Ang2), as an antagonist for Ang1, inhibits Ang1-promoted Tie2 signaling and decreases blood vessel maturation and stabilization. In a model of oxygen-induced retinopathy, Ang2 over-expression results in enhanced preretinal and intraretinal neovascularization (Feng et al., 2007) . Increased Ang2 in the vitreous fluid is associated with angiogenic activity in patients with diabetic retinopathy (Watanabe et al., 2005) . However, whether angiopoietins/Tie2 is involved in DM-induced vascular damage after ischemic brain stroke has not been investigated.
Previous studies show that type-2 DM (T2DM) rats [Goto-Kakizaki (GK)] have more bleeding than their normoglycemic controls (Wistar) after stroke (Elewa et al., 2009 ). There is significantly more frequent hematoma formation in the ischemic hemisphere and changes in vessel architecture in GK rats as opposed to controls, and these changes in blood vessels in the diabetic rats increase the risk for hemorrhagic transformation, possibly exacerbating neurovascular damage due to cerebral ischemia/reperfusion (Ergul et al., 2007) . We reported that db/ db T2DM mice exhibit significantly increased blood glucose, lesion volume, white matter damage, and have worse neurological outcome after stroke compared with non-DM mice (Chen et al., 2011) . However, whether T2DM induces vascular damage in the ischemic brain and the Neurobiology of Disease 43 (2011) 285-292 
